Black Rock Inc. Medi Wound Ltd. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.35 - $9.8 $1,753 - $12,730	-1,299 Reduced 2.79%	45,326 $63,000
Q2 2022 Aug 12, 2022	BUY	$1.33 - $2.35 $5,433 - $9,599	4,085 Added 9.6%	46,625 $86,000
Q1 2022 May 12, 2022	SELL	$1.86 - $3.24 $3,866 - $6,735	-2,079 Reduced 4.66%	42,540 $85,000
Q4 2021 Feb 10, 2022	BUY	$2.2 - $4.01 $2,541 - $4,631	1,155 Added 2.66%	44,619 $106,000
Q3 2021 Nov 09, 2021	SELL	$3.34 - $4.63 $3,086 - $4,278	-924 Reduced 2.08%	43,464 $145,000
Q2 2021 Aug 11, 2021	BUY	$3.38 - $5.71 $150,031 - $253,455	44,388 New	44,388 $170,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $686M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.